Its good they have posted this. Provides clarity to those who...

Its good they have posted this. Provides clarity to those who didn't attend or are new to the company to fully understand the preso.

I think the key point people need to recall: $20MillionUSD in government funding specifically for this antimicrobial resistance in the entire USA. LDX has 50% of that.

Again, rehashing this - AT1 rose over 30% on the news of $43MillionAUD in AUS Government budget funding, of which AT1 got all of $1.3Million.

Lumos was just granted a non refundable $4.48MillionAUD with a further circa $7.6MillionAUD for this study.